dc.contributor.author | GURBUZ, B | |
dc.contributor.author | PALANDUZ, S | |
dc.contributor.author | CEVIKBAS, A | |
dc.contributor.author | Buyukozturk, Suna | |
dc.contributor.author | GURER, US | |
dc.date.accessioned | 2021-03-03T10:27:21Z | |
dc.date.available | 2021-03-03T10:27:21Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | GURER U., Buyukozturk S., PALANDUZ S., GURBUZ B., CEVIKBAS A., "Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients", INTERNATIONAL IMMUNOPHARMACOLOGY, cilt.3, sa.9, ss.1257-1260, 2003 | |
dc.identifier.issn | 1567-5769 | |
dc.identifier.other | av_22ab035f-8189-4a04-9eb2-5c6418e46526 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/28316 | |
dc.identifier.uri | https://doi.org/10.1016/s1567-5769(03)00043-2 | |
dc.description.abstract | Leukotriene receptor antagonists are being used widely in the treatment of bronchial asthma. They have been shown to possess anti-inflammatory properties, but there is no sufficient data about their effects on polymorphonuclear leukocyte functions. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.title | Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL IMMUNOPHARMACOLOGY | |
dc.contributor.department | Marmara Üniversitesi , , | |
dc.identifier.volume | 3 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 1257 | |
dc.identifier.endpage | 1260 | |
dc.contributor.firstauthorID | 7623 | |